Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.

Risk of bias assessment of the included studies.

Karumathil M. Murali (6274142)
Judy Mullan (3706102)
Steven Roodenrys (3706108)
Hicham C. Hassan (6274145)
Kelly Lambert (6274148)
Maureen Lonergan (3706099)

January 2019

The data presented for individual risk of bias domains are based on Cochrane ROB 2.0 tool [19] for r...

Applying the Risk of Bias Tool in a Systematic Review of Combination Long-Acting Beta-Agonists and Inhaled Corticosteroids for Persistent Asthma

Hartling Lisa
Bond Kenneth
Vandermeer Ben
Seida Jennifer
Dryden Donna M.
Rowe Brian H.

February 2011

The Risk of Bias (RoB) tool is used to assess internal validity of randomized controlled trials (RCT...

Risk of bias assessed using the Revised Cochrane risk-of-bias tool for randomized trials “RoB 2”.

Francesco D’Antonio (5543813)
Nashwa Eltaweel (11337928)
Smriti Prasad (6884567)
Maria Elena Flacco (8070833)
Lamberto Manzoli (206725)
Asma Khalil (371837)

August 2023

Risk of bias assessed using the Revised Cochrane risk-of-bias tool for randomized trials “RoB 2”.</p

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.

Wagner, Carina
Griesel, Mirko
Mikolajewska, Agata
Mueller, Anika
Nothacker, Monika
Kley, Karoline
Metzendorf, Maria-Inti
Fischer, Anna-Lena
Kopp, Marco
Stegemann, Miriam
Skoetz, Nicole
Fichtner, Falk

June 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Inhaled corticosteroids for the treatment of COVID-19.

Griesel, Mirko
Wagner, Carina
Fichtner, Falk
Stegemann, Miriam
Mikolajewska, Agata
Nair, Avinash Anil
Daniel, Jefferson
Metzendorf, Maria-Inti
Skoetz, Nicole
Fischer, Anna-Lena

October 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Inhaled ...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19

Grundeis, Felicitas
Ansems, Kelly
Dahms, Karolina
Thieme, Volker
Metzendorf, Maria-Inti
Stortz, Nicole
Benstöm, Carina
Mikolajewska, Agata
Griesel, Mirko
Fichtner, Falk
Stegemann, Miriam

July 2021

Updated Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: ...

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'

Kreuzberger, Nina
Hirsch, Caroline
Chai, Khai Li
Tomlinson, Eve
Khosravi, Zahra
Popp, Maria
Neidhardt, Miriam
Salomon, Susanne
Piechotta, Vanessa
Valk, Sarah J
Monsef, Ina
Wood, Erica M
So-Osman, Cynthia
Roberts, David J
McQuilten, Zoe
Estcourt, Lise J
Skoetz, Nicole

May 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV...

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19'

Hirsch, Caroline
Park, Yun Soo
Piechotta, Vanessa
Chai, Khai Li
Estcourt, Lise J
Monsef, Ina
Salomon, Susanne
Wood, Erica M
So-Osman, Cynthia
McQuilten, Zoe
Spinner, Christoph D
Malin, Jakob J
Stegemann, Miriam
Skoetz, Nicole
Kreuzberger, Nina

December 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Hyperimmune immunoglobulin for people with COVID-19

Kimber
Valk
Chai
Piechotta
Iannizzi
Monsef
Wood
Lamikanra
Roberts
McQuilten
So-Osman
Estcourt
Skoetz

April 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Hyperimm...

Risk of bias assessments for version 5 of the Cochrane review 'Convalescent plasma for people with COVID-19'

Iannizzi, Claire
Chai, Khai Li
Piechotta, Vanessa
Valk, Sarah J
Kimber, Catherine
Monsef, Ina
Wood, Erica M
Lamikanra, Abigail A
Roberts, David J
McQuilten, Zoe
So-Osman, Cynthia
Jindal, Aikaj
Cryns, Nora
Estcourt, Lise J
Kreuzberger, Nina
Skoetz, Nicole

June 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Living Systemati...

Using Risk of Bias 2 to assess results from randomised controlled trials:guidance from Cochrane

Flemyng, Ella
Moore, Theresa HM (Tess)
Boutron, Isabelle
Higgins, Julian P T
Hróbjartsson, Asbjørn
Hansen Nejstgaard, Camilla
Dwan, Kerry

July 2023

A systematic review identifies, appraises and synthesises all the empirical evidence from studies th...

Fig 2 -

Liesbeth L. de Wall (14564096)
Antje J. Nieuwhof-Leppink (14564099)
Renske Schappin (279771)

February 2023

A. Risk of bias graph according to the Cochrane collaboration risk-of-bias RoB-2 tool for all includ...

Risk of bias assessment of the included studies.

Karumathil M. Murali (6274142)
Judy Mullan (3706102)
Steven Roodenrys (3706108)
Hicham C. Hassan (6274145)
Kelly Lambert (6274148)
Maureen Lonergan (3706099)

January 2019

The data presented for individual risk of bias domains are based on Cochrane ROB 2.0 tool [19] for r...

Applying the Risk of Bias Tool in a Systematic Review of Combination Long-Acting Beta-Agonists and Inhaled Corticosteroids for Persistent Asthma

Hartling Lisa
Bond Kenneth
Vandermeer Ben
Seida Jennifer
Dryden Donna M.
Rowe Brian H.

February 2011

The Risk of Bias (RoB) tool is used to assess internal validity of randomized controlled trials (RCT...

Risk of bias assessed using the Revised Cochrane risk-of-bias tool for randomized trials “RoB 2”.

Francesco D’Antonio (5543813)
Nashwa Eltaweel (11337928)
Smriti Prasad (6884567)
Maria Elena Flacco (8070833)
Lamberto Manzoli (206725)
Asma Khalil (371837)

August 2023

Risk of bias assessed using the Revised Cochrane risk-of-bias tool for randomized trials “RoB 2”.</p

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic corticosteroids for the treatment of COVID-19.

Wagner, Carina
Griesel, Mirko
Mikolajewska, Agata
Mueller, Anika
Nothacker, Monika
Kley, Karoline
Metzendorf, Maria-Inti
Fischer, Anna-Lena
Kopp, Marco
Stegemann, Miriam
Skoetz, Nicole
Fichtner, Falk

June 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Systemic...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Inhaled corticosteroids for the treatment of COVID-19.

Griesel, Mirko
Wagner, Carina
Fichtner, Falk
Stegemann, Miriam
Mikolajewska, Agata
Nair, Avinash Anil
Daniel, Jefferson
Metzendorf, Maria-Inti
Skoetz, Nicole
Fischer, Anna-Lena

October 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Inhaled ...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Remdesivir for the treatment of COVID-19

Grundeis, Felicitas
Ansems, Kelly
Dahms, Karolina
Thieme, Volker
Metzendorf, Maria-Inti
Stortz, Nicole
Benstöm, Carina
Mikolajewska, Agata
Griesel, Mirko
Fichtner, Falk
Stegemann, Miriam

July 2021

Updated Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: ...

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19'

Kreuzberger, Nina
Hirsch, Caroline
Chai, Khai Li
Tomlinson, Eve
Khosravi, Zahra
Popp, Maria
Neidhardt, Miriam
Salomon, Susanne
Piechotta, Vanessa
Valk, Sarah J
Monsef, Ina
Wood, Erica M
So-Osman, Cynthia
Roberts, David J
McQuilten, Zoe
Estcourt, Lise J
Skoetz, Nicole

May 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV...

Risk of bias assessments for the Cochrane review 'SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19'

Hirsch, Caroline
Park, Yun Soo
Piechotta, Vanessa
Chai, Khai Li
Estcourt, Lise J
Monsef, Ina
Salomon, Susanne
Wood, Erica M
So-Osman, Cynthia
McQuilten, Zoe
Spinner, Christoph D
Malin, Jakob J
Stegemann, Miriam
Skoetz, Nicole
Kreuzberger, Nina

December 2021

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: SARS-CoV...

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Hyperimmune immunoglobulin for people with COVID-19

Kimber
Valk
Chai
Piechotta
Iannizzi
Monsef
Wood
Lamikanra
Roberts
McQuilten
So-Osman
Estcourt
Skoetz

April 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review: Hyperimm...

Risk of bias assessments for version 5 of the Cochrane review 'Convalescent plasma for people with COVID-19'

Iannizzi, Claire
Chai, Khai Li
Piechotta, Vanessa
Valk, Sarah J
Kimber, Catherine
Monsef, Ina
Wood, Erica M
Lamikanra, Abigail A
Roberts, David J
McQuilten, Zoe
So-Osman, Cynthia
Jindal, Aikaj
Cryns, Nora
Estcourt, Lise J
Kreuzberger, Nina
Skoetz, Nicole

June 2022

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Living Systemati...

Using Risk of Bias 2 to assess results from randomised controlled trials:guidance from Cochrane

Flemyng, Ella
Moore, Theresa HM (Tess)
Boutron, Isabelle
Higgins, Julian P T
Hróbjartsson, Asbjørn
Hansen Nejstgaard, Camilla
Dwan, Kerry

July 2023

A systematic review identifies, appraises and synthesises all the empirical evidence from studies th...

Fig 2 -

Liesbeth L. de Wall (14564096)
Antje J. Nieuwhof-Leppink (14564099)
Renske Schappin (279771)

February 2023

A. Risk of bias graph according to the Cochrane collaboration risk-of-bias RoB-2 tool for all includ...

Risk of bias assessment of the included studies.

Karumathil M. Murali (6274142)
Judy Mullan (3706102)
Steven Roodenrys (3706108)
Hicham C. Hassan (6274145)
Kelly Lambert (6274148)
Maureen Lonergan (3706099)

January 2019

The data presented for individual risk of bias domains are based on Cochrane ROB 2.0 tool [19] for r...

Applying the Risk of Bias Tool in a Systematic Review of Combination Long-Acting Beta-Agonists and Inhaled Corticosteroids for Persistent Asthma

Hartling Lisa
Bond Kenneth
Vandermeer Ben
Seida Jennifer
Dryden Donna M.
Rowe Brian H.

February 2011

The Risk of Bias (RoB) tool is used to assess internal validity of randomized controlled trials (RCT...

Risk of bias assessed using the Revised Cochrane risk-of-bias tool for randomized trials “RoB 2”.

Francesco D’Antonio (5543813)
Nashwa Eltaweel (11337928)
Smriti Prasad (6884567)
Maria Elena Flacco (8070833)
Lamberto Manzoli (206725)
Asma Khalil (371837)

August 2023

Risk of bias assessed using the Revised Cochrane risk-of-bias tool for randomized trials “RoB 2”.</p

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.

Abstract

Extracted data

Risk of bias assessments and support for judgement with ROB 2 tool for the Cochrane Review-Update: Systemic corticosteroids for the treatment of COVID-19.

Abstract

Extracted data

Related items

Related items